Although miscarriage is common, recurrent pregnancy loss affects only about 1% – 2% of couples. Despite being relatively rare, RPL can be emotionally and physically challenging for those who experience it. Understanding the potential causes and undergoing proper RPL screening is essential for diagnosing and managing this condition effectively.
What is Recurrent Pregnancy Loss (RPL Test)?
Recurrent pregnancy loss (RPL) is defined as the occurrence of two or more consecutive pregnancy losses before 20 weeks of gestation. The etiology of RPL can be multifactorial, involving genetic, anatomical, endocrinological, immunological, and haematological factors.
RPL testing encompasses a series of diagnostic evaluations aimed at identifying underlying causes, including karyotyping for chromosomal abnormalities, antiphospholipid antibody testing, and assessment of uterine anatomy via imaging.
Comprehensive RPL screening may also include hormonal assays and thrombophilia testing. Early identification through an RPL panel blood test is crucial for determining personalised management strategies and improving reproductive outcomes.
How is the Test Done?
| Step | Description | |
|---|---|---|
| POC Sample Testing | A small sample of the products of conception (POC) is tested using karyotyping and FISH to detect chromosomal abnormalities. | |
| Chromosomal Microarray (CMA) | Advanced method offering in-depth analysis to identify microdeletions and microduplications that may have caused the miscarriage. |
RPL Test Benefits
- Identifies if pregnancy loss resulted from genetic/chromosomal abnormality
- Offers insights for patients and physicians regarding the loss's cause
- Creates a plan to enhance future pregnancy success
Specifications
- Sample type: Pulmonary and extra-pulmonary samples
- Sequencing Method: Next-generation sequencing (NGS) culture free
- Sensitivity: 100% (compared to LPA as reference standard)
- Specificity: 98.04% (compared to LPA as reference standard)
- Drugs Tested: 20+
- Strain Typing: Yes
- Turnaround Time: 10-14 days
Key Highlights of MedGenome Labs Recurrent Pregnancy Loss Test
Highly Sensitive Detection
Detects chromosomal deletions and duplications using a highly sensitive platform with over 99% sensitivity.
Comprehensive Genome Coverage
Increased whole-genome coverage targeting 396 relevant regions for prenatal analysis (18,018 CNVs and 148,450 SNPs).
Enhanced Coverage Density
Increased coverage density of (25 markers/100 kb) in 396 empirically selected regions relevant for prenatal research.
Get Genetic Counseling with
MedGenome Genetic Experts

Please share your details with our genetic experts to answer your queries
MedGenome Patient Stories
MedGenome in the News
Download SPIT SEQ Brochures
Discover how we can support your wellness through our diverse range of tests. Our brochure provides an in-depth look at our commitment to quality care and patient satisfaction.
Please share your details to get
in touch with our experts.














